Nevertheless, by BLT we could not identify an additional effect of IL-2 on EGFR CAR T cell and BDCA-2 CAR T cell expansion at the tumor, since an overall higher signal in the whole mouse ROI was detected in IL-2-treated mice. This evidence concerns the gene EGFR and neoplasm.